TPI-1 5 mg | 99.79%
TargetMol
TPI-1
Search Results
TPI-1 50 mg | 99.79%
TargetMol
TPI-1
TPI-1 25 mg | 99.79%
TargetMol
TPI-1
TPI-1 10 mg | 99.79%
TargetMol
TPI-1
SR9009 5 mg | 99.80%
TargetMol
SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM). Through activation of REV-ERB, SR9009 can decrease circadian locomotor activity during the dark phase and alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes […]
More Information Supplier PageSR9009
SR9009 50 mg | 99.80%
TargetMol
SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM). Through activation of REV-ERB, SR9009 can decrease circadian locomotor activity during the dark phase and alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes […]
More Information Supplier PageSR9009
SR9009 25 mg | 99.80%
TargetMol
SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM). Through activation of REV-ERB, SR9009 can decrease circadian locomotor activity during the dark phase and alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes […]
More Information Supplier PageSR9009
SR9009 10 mg | 99.80%
TargetMol
SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM). Through activation of REV-ERB, SR9009 can decrease circadian locomotor activity during the dark phase and alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes […]
More Information Supplier PageSR9009
SR9009 100 mg | 99.80%
TargetMol
SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM). Through activation of REV-ERB, SR9009 can decrease circadian locomotor activity during the dark phase and alter the expression pattern of core clock genes in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes […]
More Information Supplier PageSR9009
Atractylodin 10 mg | 99.74%
TargetMol
Atractylodin has high lipase inhibitory activity (IC5:39.12 μM); Atractylodin possesses strong repellency activities against T. castaneum adults (LD50: 1.83 μg/cm). The repellency of Atractylodin (0.63 μg/cm) can achieve >90%.
More Information Supplier PageAtractylodin
